HGHRX
Price
$33.33
Change
+$0.38 (+1.15%)
Updated
Jul 16 closing price
Net Assets
765.89M
JFNIX
Price
$66.97
Change
+$0.84 (+1.27%)
Updated
Jul 16 closing price
Net Assets
4.4B
Interact to see
Advertisement

HGHRX vs JFNIX

Header iconHGHRX vs JFNIX Comparison
Open Charts HGHRX vs JFNIXBanner chart's image
Hartford Healthcare R3
Price$33.33
Change+$0.38 (+1.15%)
VolumeN/A
Net Assets765.89M
Janus Henderson Global Life Sciences I
Price$66.97
Change+$0.84 (+1.27%)
VolumeN/A
Net Assets4.4B
HGHRX vs JFNIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HGHRX vs. JFNIX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a Hold and JFNIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.4B vs. HGHRX (766M). JFNIX pays higher dividends than HGHRX: JFNIX (0.41) vs HGHRX (0.00). HGHRX was incepted earlier than JFNIX: HGHRX (19 years) vs JFNIX (16 years). HGHRX (1.63) is less costly to investors than JFNIX (0.77). HGHRX is a more actively managed with annual turnover of: 40.00 vs. JFNIX (35.00). HGHRX has a lower initial minimum investment than JFNIX: HGHRX (0) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -17.51 vs. HGHRX (-21.23). JFNIX return over 5 years is better than : 1.36 vs. HGHRX (-22.23).
HGHRXJFNIXHGHRX / JFNIX
Total Expense Ratio1.630.77212%
Annual Report Gross Expense Ratio1.630.77212%
Fund Existence19 years16 years-
Gain YTD-7.026-2.779253%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets766M4.4B17%
Annual Yield % from dividends0.000.41-
Returns for 1 year-21.23-17.51121%
Returns for 3 years-6.847.86-87%
Returns for 5 years-22.231.36-1,633%
Returns for 10 years-25.554.97-514%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FINSX48.28N/A
N/A
Fidelity Advisor New Insights I
TDEIX32.14N/A
N/A
Transamerica US Growth I
HSUCX32.69N/A
N/A
Rational Dynamic Brands C
AVUNX19.46N/A
N/A
Avantis® U.S. Equity G
PRCFX28.29N/A
N/A
T. Rowe Price Cap Apprec And Inc